ARCHIVES

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

This article is from The Cancer Letter archive.

Vol. 24 No. 09 | March 6, 1998

Download PDF Visit The Full Archive

Related Articles

Sprycell Approved for CML

November 5, 2010

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

The Cancer Letter Stands By Story

October 30, 1998

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006

NCI Trials Listed

June 25, 2010

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

March 11, 1988